| For: | Kang LM, Yu DP, Zheng Y, Zhou YH. Primary squamous cell carcinoma of the liver: A case report. World J Clin Cases 2022; 10(19): 6744-6749 [PMID: 35979286 DOI: 10.12998/wjcc.v10.i19.6744] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/6744.htm |
| Number | Citing Articles |
| 1 |
Lin Zhao, Yan Zhou, Jianmin Ding, Zhengyi Qin, Hongyu Zhou, Xiang Jing. Primary hepatic squamous cell carcinoma: case report and systematic review of the literature. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1229936
|
| 2 |
Jian Jiang, Guomin Dong, Suoni Li, Jiequn Ma, Jie Bai, Jinzi Hui, Hongbian Gao, Zheng Zhao. Immunotherapy for primary squamous cell carcinoma of the liver: A case report. Oncology Letters 2025; 29(6): 1 doi: 10.3892/ol.2025.15025
|
| 3 |
Soo Ryang Kim, Soo Ki Kim, Hisato Kobayashi, Toyokazu Okuda, Yumi Fujii, Makiho Sakamoto, Yu-ichiro Koma, Osamu Nakashima, Motoko Sasaki, Akira Asai, Hiroki Nishikawa. Primary Hepatic Squamous Cell Carcinoma. Diagnostics 2026; 16(1): 120 doi: 10.3390/diagnostics16010120
|
| 4 |
Ryogo Minami, Masamichi Kimura, Koji Nishikawa, Jun Imamura, Kiminori Kimura. Clinical Outcomes of Hepatic Squamous Cell Carcinoma With Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation: A Case Report. Cureus 2025; doi: 10.7759/cureus.78024
|
